Optimized Workflow for Iterative Bleaching Extends Multiplexity Imaging of Highly Autofluorescent Clinical Samples.
Aleksandra Lunich, Andrea J Radtke, Margaret Williams...
https://pubmed.ncbi.nlm.nih.gov/40720370/Actively Recruiting
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2026-07-13
900
Participants Needed
1
Research Sites
N/A
Total Duration
Bronchiectasis is a condition marked by inflamed, abnormally widened airways prone to chronic and recurring infections affecting the respiratory tract including sinuses, ears, and lungs. This condition remains a major concern in certain populations, such as those with cystic fibrosis, and continues to pose challenges in developing countries. Researchers are studying bronchiectasis to understand inherited and immune factors that cause some individuals to experience ongoing infections. This observational study involves patients aged 5 years and older with bronchiectasis or chronic respiratory infections, along with some of their direct family members. Participants will undergo evaluations including medical history reviews, respiratory symptom questionnaires, and standard procedures like nasal air sampling, lung imaging, lung function tests, and collection of blood, urine, and sputum samples. Family members may provide blood or cheek swab samples for genetic testing. Patients will continue to receive standard care to prevent infections and disease progression during the study. Participants will be seen at least every six months for the first two years and then at intervals ranging from one to five years, continuing for up to five years or until they choose to stop. During visits, researchers will monitor disease progression and gather information on factors linked to bronchiectasis. Assessments include clinical evaluations, questionnaires, imaging, lung function tests, and sample collections. The study aims to identify causes of bronchiectasis and to better understand its development and management over time.
CONDITIONS
Natural History of Bronchiectasis
C
Chevalia J Robinson, R.N.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Heart, Lung, and Blood Institute (NHLBI)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 5 years
Participants will be evaluated at least every six months for the first two years, then at intervals of one to five years, for up to five years or until they choose to stop. Assessments include medical history updates, questionnaires, imaging, lung function tests, and sample collections to track disease progression and understand bronchiectasis.
Visits at least every 6 months for first 2 years, then every 1-5 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Aleksandra Lunich, Andrea J Radtke, Margaret Williams...
https://pubmed.ncbi.nlm.nih.gov/40720370/National Heart, Lung, and Blood Institute (NHLBI)
Lead Sponsor